Sales and earnings (Q1 2023)
- Net revenue
- 523,2 MSEK (+39%)
- Op. EBITDA
- 107,4 MSEK (+20,5%)
Financial reports
Calendar
- June 7
- Handelsbanken Nordic Mid/Small Cap Seminar 2023 - Stockholm
- July 27
- Half-Year Report 2023
- September 14
- Pareto Healthcare Seminar (Stockholm)
Pressreleases & news
- Symrise has published a mandatory tender offer to the shareholders of Swedencare
- JUNE 7 2023 09:00
- Notice of Annual general meeting in Swedencare AB (publ)
- MARCH 28 2023 1:00
- Swedencare AB (publ) YEAREND REPORT January 1 – December 31, 2022
- FEBRUARY 16 2023 8:00
- Employees in the Swedencare Group acquire warrants
- DECEMBER 12 2022 10:30
Latest presentations
Presentation of Q1 2023
”The first quarter’s net sales of 523.2 MSEK represented an increase of 39% compared to Q1 2022 and is our strongest quarter ever. Our organic growth (10%) is better than the market and this is how it should be when our synergy and business development projects show results.” – Håkan Lagerberg, CEO
